These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 202718)

  • 1. Complement-dependent cytotoxic antitumor antibody. I. Immunoglobulin class determined by interaction with protein A or concanavalin A.
    Langone JJ; Boyle MD; Borsos T
    J Natl Cancer Inst; 1978 Feb; 60(2):411-8. PubMed ID: 202718
    [No Abstract]   [Full Text] [Related]  

  • 2. Augmentation of tumor-specific immunogenicity by concanavalin A in the Morris hepatoma 5123.
    Enker WE; Craft K; Wissler RW
    J Surg Res; 1974 Jan; 16(1):66-8. PubMed ID: 4131863
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of concanavalin A on the killing of tumor cells by antibody and complement.
    Boyle MD; Langone JJ; Ohanian SH; Borsos T
    J Immunol; 1977 May; 118(5):1626-30. PubMed ID: 192797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of tumor cells by antibody and complement. 1. Lack of correlation between antigen content and lytic susceptibility.
    Ohanian SH; Borsos T; Rapp HJ
    J Natl Cancer Inst; 1973 May; 50(5):1313-20. PubMed ID: 4351395
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro effects of antitumor antibody--chemotactic factor complexes.
    Obrist R; Sandberg AL
    Clin Immunol Immunopathol; 1982 Oct; 25(1):91-102. PubMed ID: 6295673
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metabolic inhibitors on killing of tumor cells by antibody and complement.
    Segerling M; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1974 Nov; 53(5):1411-3. PubMed ID: 4372384
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bleomycin-induced tumor cell lysis caused by antibodies and complement].
    Bier J; Ohanian SH
    Dtsch Zahnarztl Z; 1980 Jan; 35(1):102-4. PubMed ID: 6157512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of protease treatment on the sensitivity of tumor cells to antibody-GPC killing.
    Boyle MD; Ohanian SH; Boros T
    Clin Immunol Immunopathol; 1978 May; 10(1):84-94. PubMed ID: 207478
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistance of guinea-pig hepatoma cells to complement-mediated lysis induced by ascites fluid or serum from tumor-bearing animals.
    Abe S; Berczi I; Sehon AH
    Int J Cancer; 1977 Oct; 20(4):595-606. PubMed ID: 199549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment.
    Boyle MD; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical detection of tumor-specific and embryonic antigens of diethylnitrosamine-induced guinea pig tumors.
    Borsos T; Richardson AK; Ohanian SH; Leonard EJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1955-60. PubMed ID: 4128823
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy with tumor cells and BCG in the guinea pig, studied by immunological in vivo and in vitro experiments.
    Rella W; Chaput B
    Oncology; 1978; 35(3):136-42. PubMed ID: 209379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to and escape from complement-mediated lysis of guinea-pig hepatoma line-10.
    Abe S; Berczi I; Sehon AH
    Int J Cancer; 1977 Jul; 20(1):137-45. PubMed ID: 198379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of immunoglobulin and complement components C4 and C3 bound to guinea pig tumor cells.
    Segerling M; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1976 Jul; 57(1):145-50. PubMed ID: 187759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of concanavalin A on the functional activity of hemolytic antibody.
    Langone JJ; Boyle MD; Borsos T
    Immunol Commun; 1977; 6(3):283-96. PubMed ID: 885582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-dependent cytotoxicity against hepatoma cells mediated by IgM antibodies in serum from tumor-bearing rats.
    Lando P; Blomberg F; Raftell M; Berzins K; Perlmann P
    Scand J Immunol; 1977; 6(11):1081-92. PubMed ID: 202015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune responses to tumor-specific antigens in strain-2 guinea pigs.
    Smith HG; Leonard EJ
    J Natl Cancer Inst; 1974 Jul; 53(1):187-94. PubMed ID: 4366195
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement-dependent cytotoxic antitumor antibody. II. Quantitative determination of cell-bound immunoglobulin M1.
    Boyle MD; Langone JJ
    J Natl Cancer Inst; 1979 Jun; 62(6):1537-44. PubMed ID: 286124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing effect by metabolic inhibitors on the killing of tumor cells by antibody and complement.
    Segerling M; Ohanian SH; Borsos T
    Cancer Res; 1975 Nov; 35(11 Pt 1):3195-203. PubMed ID: 52404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.